Management of the premature infant with a patent ductus arteriosus

Pediatr Clin North Am. 1984 Dec;31(6):1159-74. doi: 10.1016/s0031-3955(16)34715-0.

Abstract

The maturation of the lung is one of the greatest challenges the premature infant must face after birth. Premature infants have been observed to have a higher prevalence of patency of the ductus arterious, presenting the physician with a dilemma and a challenge. This article discusses the clinical and pathophysiologic manifestations and the management of patent ductus arteriosus in the premature infant.

MeSH terms

  • Blood Transfusion
  • Cardiac Catheterization
  • Digoxin / therapeutic use
  • Diuresis / drug effects
  • Ductus Arteriosus, Patent / diagnosis
  • Ductus Arteriosus, Patent / drug therapy
  • Ductus Arteriosus, Patent / surgery
  • Ductus Arteriosus, Patent / therapy*
  • Echocardiography
  • Heart Murmurs
  • Humans
  • Indomethacin / administration & dosage
  • Indomethacin / adverse effects
  • Indomethacin / therapeutic use
  • Infant, Newborn
  • Infant, Premature, Diseases / diagnosis
  • Infant, Premature, Diseases / drug therapy
  • Infant, Premature, Diseases / surgery
  • Infant, Premature, Diseases / therapy*

Substances

  • Digoxin
  • Indomethacin